Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
JOURNALS
PSYCHOPHARMACOLOGY BULLETIN
FULL ISSUE STACKED PDFs
T.E.N.
MENTAL FITNESS
PSI
ONCOLOGY SPECTRUMS
PROJECTS
JOURNAL SUPPLEMENTS
PHYSICIAN ACADEMY SERIES
POCKET REFERENCE GUIDES
TEACHING MONOGRAPHS
MEDWORKS REPRINT SERIES
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOTROPIC PRESCRIBING INFORMATION
PSYCHOTROPIC DOSAGE RANGES
PSYCHOPHARMACOLOGY 101
PSYCHIATRIC RATING SCALES
NEWS
WE KNOW PSYCHIATRY
FEATURED ARTICLES
Home
Thomas L. Schwartz, MD: Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series
Thomas L. Schwartz, MD: Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series
$
30.00
Thomas L. Schwartz, MD: Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series quantity
Add to cart
Want a discount? Become a member by purchasing
Psychopharmacology Bulletin Subscription - Individual
!
Categories:
Psychopharmacology Bulletin
,
VOL 37 No. 1 Articles
Tags:
antidepressants
,
antipsychotics
,
mark-beale
,
medworks-media
,
obesity
,
psychopharmacology-bulletin
,
thomas-l-schwartz
,
weight-management
Description
Description
Thomas L. Schwartz, MD
CASE HISTORIES
Psychotropic Drug-Induced Weight Gain Alleviated with Orlistat: A Case Series
Thomas L. Schwartz, MD, and Mark Beale, MD
Share On Facebook
Tweet This Product
Pin This Product
Email This Product
Related products
Paroxysmal Perceptual Alteration Case Study by Samir Kumar Praharaj
$
30.00
Add to cart
Details
Long Acting Risperidone in an Adolescent – Mustafa Deniz Tutkunkardas
$
30.00
Add to cart
Details
Zonisamide for Bipolar Disorder, Mania or Mixed States by Deborah Dauphinais
$
30.00
Add to cart
Details
Paliperidone Double-blind, Placebo- and Active-Controlled, Study
$
30.00
Add to cart
Details
Page load link
Go to Top
